Lifeint and the First Affiliated Hospital of Xiamen University published nasopharyngeal cancer research in the Journal of Experimental & Clinical Cancer Research. The original announcement listed an impact factor of 5.189 at the time and named Xiamen LifeInt Technology Co., Ltd. as an author affiliation.
Read the original article: https://jeccr.biomedcentral.com/articles/10.1186/s13046-018-0769-4
Lifeint provides EV research and application services from sample preparation, isolation and characterization to omics, functional studies, modification and scale-up. It jointly established a biomedical technology centre with Xiamen University School of Pharmaceutical Sciences, built process-development laboratories to GMP standards, and contributed to an EV expert consensus. Its service records cover more than 300 plant species.
Scan to contact us on WeCom
